ArticleOncotarget2018

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas.

Stefania Acciardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.